Vaccination in the elderly: an immunological perspective.

Successful vaccination of the elderly against important infectious pathogens that cause high morbidity and mortality represents a growing public health priority. Building on the theme of aging and immunosenescence, we review mechanisms of human immunosenescence and the immune response to currently licensed vaccines. We discuss the difficulties in identifying the risk factors that, in addition to aging, cause immunosenescence and address the relative paucity of vaccine studies in the elderly. We conclude that vaccine responses are blunted in the elderly compared with that of healthy young adults. However, it is also clear that our understanding of the mechanisms underlying immunosenescence is limited and much remains to be learned to improve the effectiveness of next generation vaccines.

[1]  R. Kumar,et al.  Age-related decline in immunity: implications for vaccine responsiveness , 2008, Expert review of vaccines.

[2]  K. Nichol,et al.  Immune function and vaccine responses in healthy advanced elderly patients. , 2000, Archives of internal medicine.

[3]  R. Effros.  Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly. , 1998, American journal of human genetics.

[4]  N. Gualde,et al.  Hepatitis-B vaccination in the elderly. , 1984, The Journal of infectious diseases.

[5]  E. van der Velde,et al.  Correlation between the antibody response to influenza vaccine and helper T cell subsets in healthy aging. , 1996, Vaccine.

[6]  Onchee Yu,et al.  Effectiveness of pneumococcal polysaccharide vaccine in older adults. , 2003, The New England journal of medicine.

[7]  Cecile Viboud,et al.  Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.

[8]  C. Franceschi,et al.  The immune system in extreme longevity , 2008, Experimental Gerontology.

[9]  S. Gravenstein,et al.  Granzyme B: a marker of risk for influenza in institutionalized older adults. , 2001, Vaccine.

[10]  J. Myśliwska,et al.  Immunomodulating effect of influenza vaccination in the elderly differing in health status , 2004, Experimental Gerontology.

[11]  M. Clements,et al.  Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens. , 1994, The Journal of infectious diseases.

[12]  A. Kumar.  Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults , 2006 .

[13]  R. Belshe,et al.  Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and "original antigenic sin". , 1994, The Journal of infectious diseases.

[14]  S. Halperin,et al.  Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  S. Halperin,et al.  Morbidity of pertussis in adolescents and adults. , 2000, The Journal of infectious diseases.

[16]  D N Posnett,et al.  Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy" [published erratum appears in J Exp Med 1994 Mar 1;179(3):1077] , 1994, The Journal of experimental medicine.

[17]  G. Pawelec,et al.  From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly , 2009, Biogerontology.

[18]  H. Müller-Hermelink,et al.  Admission criteria for immunogerontological studies in man: The senieur protocol , 1984, Mechanisms of Ageing and Development.

[19]  C. Harley,et al.  Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes1 , 2008, The Journal of Immunology.

[20]  K. Pfeiffer,et al.  Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. , 2005, Vaccine.

[21]  C. Harley,et al.  Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. , 1996, AIDS.

[22]  C. Vitek,et al.  Diphtheria in the Russian Federation in the 1990s. , 2000, The Journal of infectious diseases.

[23]  K. Nichol,et al.  Effectiveness of influenza vaccine in the community-dwelling elderly. , 2007, The New England journal of medicine.

[24]  Trang Vu,et al.  A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. , 2002, Vaccine.

[25]  P. Kourilsky,et al.  Expanded CD4+ and CD8+ T cell clones in elderly humans. , 1997, Journal of immunology.

[26]  Mark A. Miller,et al.  Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. , 2006, Vaccine.

[27]  J. Blumberg,et al.  Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. , 1997, JAMA.

[28]  C. Ewen,et al.  T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly1 , 2006, The Journal of Immunology.

[29]  R. Seufert,et al.  CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7 , 2002, Zentralblatt fur Gynakologie.

[30]  G. Pawelec,et al.  Large Numbers of Dysfunctional CD8+ T Lymphocytes Bearing Receptors for a Single Dominant CMV Epitope in the Very Old , 2003, Journal of Clinical Immunology.

[31]  J. Norris,et al.  Letter: G.A.B.A. in Huntington's chorea. , 1974, Lancet.

[32]  D. Fedson,et al.  Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults. , 2004, Vaccine.

[33]  K. Leder,et al.  Travel vaccines and elderly persons: review of vaccines available in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  D. Jenkinson.  Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study , 1988, British medical journal.

[35]  Ping Li,et al.  Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age. , 2009, Vaccine.

[36]  N. Gualde,et al.  Alterations in the human immune response to the hepatitis B vaccine among the elderly. , 1987, Cellular immunology.

[37]  W. Bancroft,et al.  Immunogenicity of an inactivated hepatitis A vaccine. , 1991, Annals of internal medicine.

[38]  S. de Rave,et al.  Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers. , 1994, Vaccine.

[39]  V. Valcour,et al.  Tetanus Immunity in Long‐Term Care Facilities , 2003, Journal of the American Geriatrics Society.

[40]  B. Thiers.  A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults , 2006 .

[41]  A. Razmpour,et al.  Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  E. Schiff,et al.  Immunogenicity of two recombinant hepatitis B vaccines in older individuals. , 1993, The American journal of medicine.

[43]  J. Hadler,et al.  Hepatitis B vaccine responsiveness in Connecticut public safety personnel. , 1993, JAMA.

[44]  G. Pawelec,et al.  Is immunosenescence infectious? , 2004, Trends in immunology.

[45]  Tom Jefferson,et al.  Vaccines for preventing influenza in the elderly. , 2010, The Cochrane database of systematic reviews.

[46]  K. Pfeiffer,et al.  Circulating cytotoxic CD8+ CD28- T cells in ankylosing spondylitis , 2001, Arthritis research.

[47]  K. Alagappan,et al.  Antibody protection to diphtheria in geriatric patients: need for ED compliance with immunization guidelines. , 1997, Annals of emergency medicine.

[48]  G. Fara,et al.  Immune response of the elderly to rabies vaccines. , 1994, Vaccine.

[49]  P. Gergen,et al.  A population-based serologic survey of immunity to tetanus in the United States. , 1995, The New England journal of medicine.

[50]  G. Schiffman,et al.  Impaired Antibody Responses to Pneumococcal Polysaccharide in Elderly Patients with Low Serum Vitamin B12 Levels , 1996, Annals of Internal Medicine.

[51]  E. Hoster,et al.  Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. , 2006, Vaccine.

[52]  R. Effros.  Replicative senescence: the final stage of memory T cell differentiation? , 2003, Current HIV research.

[53]  T. Ceddia,et al.  Antibody response to rabies vaccine prepared in tissue cultures of human diploid cells and inactivated, evaluated in different classes of age. , 1982, Annali Sclavo; rivista di microbiologia e di immunologia.

[54]  D. Knook,et al.  Necessity of the assessment of health status in human immunogerontological studies: Evaluation of the senieur protocol , 1990, Mechanisms of Ageing and Development.

[55]  R. Effros,et al.  Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation☆ , 1999, Experimental Gerontology.

[56]  K. Pillay.  Congenital Hypothyroidism and Immunodeficiency: Evidence for an Endocrine-Immune Interaction , 1998, Journal of pediatric endocrinology & metabolism : JPEM.

[57]  Silvia Maggini,et al.  Contribution of Selected Vitamins and Trace Elements to Immune Function , 2007, Annals of Nutrition and Metabolism.

[58]  A. Detsky,et al.  Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. , 1994, Archives of internal medicine.

[59]  K. Leder,et al.  The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[60]  R. Edelman,et al.  Clinical evaluation of adjuvants , 2006 .

[61]  Cecile Viboud,et al.  Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. , 2007, The Lancet. Infectious diseases.

[62]  D. Knook,et al.  Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. , 1999, The Journal of infectious diseases.

[63]  S. Gravenstein,et al.  Efficacy of an Influenza Hemagglutinin‐Diphtheria Toxoid Conjugate Vaccine in Elderly Nursing Home Subjects During an Influenza Outbreak , 1994, Journal of the American Geriatrics Society.

[64]  Mark M Davis,et al.  A prescription for human immunology. , 2008, Immunity.

[65]  M. Katsurada,et al.  A field trial with an improved Japanese encephalitis vaccine in a nonendemic area of the disease. , 1970, Biken journal.

[66]  W. O'Fallon,et al.  Value of Immunological Markers in Predicting Responsiveness to Influenza Vaccination in Elderly Individuals , 2001, Journal of Virology.

[67]  R. Detels,et al.  Premature Aging of T cells Is Associated With Faster HIV-1 Disease Progression , 2009, Journal of acquired immune deficiency syndromes.

[68]  C. Franceschi,et al.  Massive Load of Functional Effector CD4+ and CD8+ T Cells against Cytomegalovirus in Very Old Subjects1 , 2007, The Journal of Immunology.

[69]  S. Castle,et al.  Clinical relevance of age-related immune dysfunction. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  S. le Cessie,et al.  Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. , 1997, Vaccine.

[71]  C. Franceschi,et al.  Cytomegalovirus Infection , 2007, Annals of the New York Academy of Sciences.

[72]  G. Pawelec,et al.  Compromised interferon gamma (IFN-gamma) production in the elderly to both acute and latent viral antigen stimulation: contribution to the immune risk phenotype? , 2002, European cytokine network.

[73]  G. Leroux-Roels,et al.  Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. , 2008, Vaccine.

[74]  E. Yunis,et al.  The immune response to hepatitis B vaccine in humans: inheritance patterns in families , 1992, The Journal of experimental medicine.

[75]  E. Gardner,et al.  Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly , 2002, Experimental Gerontology.

[76]  D. Skowronski,et al.  Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? , 2008, The Journal of infectious diseases.

[77]  P. Gregersen,et al.  Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset. , 1995, Journal of immunology.

[78]  V. Schijns.  Immunopotentiators in modern vaccines , 2003 .

[79]  R. Breiman,et al.  Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997 .

[80]  G. Carlone,et al.  Elderly immune response to a TI-2 antigen: heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide. , 1999, The Journal of infectious diseases.

[81]  V Demicheli,et al.  Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review , 2005, The Lancet.

[82]  H. Sacks,et al.  The Efficacy of Influenza Vaccine in Elderly Persons , 1995, Annals of Internal Medicine.

[83]  P. Peduzzi,et al.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. , 2005, The New England journal of medicine.

[84]  E. Barnett.  Yellow fever: epidemiology and prevention. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[85]  G. Ligthart,et al.  Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay , 1998, Journal of medical virology.

[86]  D. Frasca,et al.  Heterogeneity of immune responsiveness in healthy elderly subjects. , 1988, Clinical immunology and immunopathology.

[87]  C. Llor,et al.  Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[88]  M. L. Clements-Mann,et al.  Immunogenicity of two doses of yeast recombinant hepatitis B vaccine in healthy older adults. , 1997, The Journal of infectious diseases.

[89]  R. Tampi,et al.  Valproic Acid-Induced Hyperammonemia in the Elderly: A Review of the Literature , 2009, Case reports in medicine.

[90]  J. Myśliwska,et al.  Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. , 2003, Vaccine.

[91]  D. Breuillé,et al.  The inflammatory response to vaccination is altered in the elderly , 2005, Mechanisms of Ageing and Development.

[92]  Malbea A Lapete,et al.  Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2004 .

[93]  G. Pawelec,et al.  Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? , 1997, Immunology today.

[94]  C. Alper.  The human immune response to hepatitis B surface antigen. , 1995, Experimental and clinical immunogenetics.

[95]  F. Fabrizi,et al.  Meta‐analysis: the effect of age on immunological response to hepatitis B vaccine in end‐stage renal disease , 2004, Alimentary pharmacology & therapeutics.

[96]  R. Edelman,et al.  Mechanisms of defective delayed cutaneous hypersensitivity in children with protein-calorie malnutrition. , 1973, Lancet.

[97]  S. Hadler,et al.  Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. , 1989, Vaccine.

[98]  B. Grubeck‐Loebenstein,et al.  [Immune reaction to tetanus in the elderly: what is the duration of vaccine protection?]. , 1997, Wiener klinische Wochenschrift.

[99]  P. Galan,et al.  Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. , 1999, Archives of internal medicine.

[100]  C. Bellak,et al.  Hepatitis A vaccination. , 1998, The New England journal of medicine.

[101]  A. Amadori,et al.  Quantitative and qualitative analysis of anti-tetanus toxoid antibody response in the elderly. Humoral immune response enhancement by thymostimulin. , 1993, Vaccine.

[102]  Sandra Romero-Steiner,et al.  Use of Opsonophagocytosis for Serological Evaluation of Pneumococcal Vaccines , 2006, Clinical and Vaccine Immunology.

[103]  R. Ciubotariu,et al.  CD8+CD28− T suppressor cells and the induction of antigen‐specific, antigen‐presenting cell‐mediated suppression of Th reactivity , 2001, Immunological reviews.

[104]  Cécile Viboud,et al.  Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.

[105]  E. Gardner,et al.  Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. , 2006, Vaccine.

[106]  B. Grubeck‐Loebenstein,et al.  No immunity for the elderly , 1998, Nature Medicine.

[107]  C. Franceschi,et al.  Centenarians as a model for healthy aging. , 2003, Biochemical Society transactions.

[108]  C. Kallenberg,et al.  Influence of ageing on antibody formation in vivo after immunisation with the primary T-cell dependent antigen Helix pomatia haemocyanin , 1992, Mechanisms of Ageing and Development.

[109]  Walther Parson,et al.  Lack of Antibody Production Following Immunization in Old Age: Association with CD8+CD28− T Cell Clonal Expansions and an Imbalance in the Production of Th1 and Th2 Cytokines1 , 2002, The Journal of Immunology.

[110]  Robert T. Chen,et al.  Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. , 2005, Vaccine.

[111]  K. High.  Immunizations in older adults. , 2007, Clinics in geriatric medicine.

[112]  R. Effros,et al.  Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. , 2002, Clinical immunology.

[113]  T. Whiteside,et al.  Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer , 2003, Cancer Immunology, Immunotherapy.